release 14.13 statistical software (Minitab Inc)
90
Structured Review
Minitab Inc
release 14.13 statistical software
Release 14.13 Statistical Software, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14%2E13+software/software+version+16/10__1016_slash_j__bse__2021__104275-111-19-23
Average 90 stars, based on 1 article reviews
Release 14.13 Statistical Software, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14%2E13+software/software+version+16/10__1016_slash_j__bse__2021__104275-111-19-23
Average 90 stars, based on 1 article reviews
release 14.13 statistical software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Western Blot:Article Title: Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents. Article Snippet: Background: Although risk factors for torsade de pointes (TdP) are known, identifying hospitalized patients at greatest risk for QTcP who should receive cardiac monitoring is poorly defined.. Objectives: Describe the prevalence of risk for TdP in patients and associations between risk factors and QTc prolongation (QTcP) at a tertiary teaching hospital.. Methods: This retrospective analysis assessed physiological and pharmacological risk factors for TdP of adult patients receiving ≥1 QTc-prolonging medications (QTcMed) during hospitalization. Article Title: Characterization of the Humoral Immune Response against Gnathostoma binucleatum in Patients Clinically Diagnosed with Gnathostomiasis Article Snippet: Frequencies of recognition of different proteins in Western blot assays were analyzed by using the chi-square test and Software:Article Title: Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents. Article Snippet: Background: Although risk factors for torsade de pointes (TdP) are known, identifying hospitalized patients at greatest risk for QTcP who should receive cardiac monitoring is poorly defined.. Objectives: Describe the prevalence of risk for TdP in patients and associations between risk factors and QTc prolongation (QTcP) at a tertiary teaching hospital.. Methods: This retrospective analysis assessed physiological and pharmacological risk factors for TdP of adult patients receiving ≥1 QTc-prolonging medications (QTcMed) during hospitalization. Article Title: Characterization of the Humoral Immune Response against Gnathostoma binucleatum in Patients Clinically Diagnosed with Gnathostomiasis Article Snippet: Frequencies of recognition of different proteins in Western blot assays were analyzed by using the chi-square test and |